home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Scientists Greatly Simplify Model of how cancer Starts

 
  May, 21 2002 2:47
your information resource in human molecular genetics
 
     
Scientists Greatly Simplify Model of how cancer Starts

Researchers in the University of Warwick’s Molecular Medicine Research Centre have undermined the old complex model of how many cancers start and identified a single protein known as c-Myc as a “mission-critical target for effective cancer therapies.”

Current cancer models suggest that a network of several cell mutations is needed to begin a cancer such a complex origin makes it difficult to find simple causes or easy targets that can be tackled. Treatment of developed cancers often have thus to be aggressive therapies to destroy the cancerwith high risks of damage to healthy tissue.


But new work by Dr. Stella Pelengaris, and Dr Mike Khan at the University of Warwick’s Molecular Medicine Research Centre has undermined the old complex model of how a cancer start and identified a single protein known as c-Myc as a “mission-critical target for effective cancer therapies.”

Contact:
Dr. Mike Khan
mkhan@bio.warwick.ac.uk
44-247-652-8975
University of Warwick


Message posted by: Wouter Kalle

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.